News

Evotaz (atazanavir 300mg and cobicistat 150mg) tablets are approved for use in combination with other antiretroviral agents to treat HIV-1 infected adults without known mutations associated with resistance

Currently, benralizumab is in Phase III development for the treatment of severe uncontrolled asthma and COPD. Benralizumab targets the IL-5 receptor and reduces eosinophils, which play a major

The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), as part of the National Institutes of Health (NIH), an agency of the United

The transaction provides Panther Biotechnology with a proprietary, multinational patent protected, ligand-drug conjugate technology platform as well as a pipeline of drug product candidates that address unmet medical

"The issuance of this 9th U.S. patent in our global RPE portfolio represents yet another example of the leadership position we have established as pioneers in Regenerative Ophthalmology,"

"Strong partnerships and coordination across our global study base to identify eligible patients and collect tumor samples have led to successful enrollment for the largest clinical trial ever

The new products, Fertility and Lactation, launched in June 2015 at drinkpremama.com and retailers nationwide. "For many, the maternity journey includes the introduction to vitamins, fertility supplements, heartburn,

Leveraging its comprehensive protein library and proprietary in vivo screening technologies, Five Prime identified GITR as one of the most potent inhibitors of tumor growth. GITR is an

Under the deal, Celgene will pay $232 per share in cash for Receptos, which is focused on developing therapeutic candidates for the treatment of immune and metabolic diseases.